Skip to main content
. 2019 Jan 8;6(3):420–430. doi: 10.1002/acn3.714

Table 1.

Participant characteristics

Study 1 Study 2
SAH Control P SAH
Number 39 19 21
Age (years)a 59, 35–79 57, 26–76 NSc 57, 30–76
Modified Fisher gradeb
0 2, 5%
1 7, 18%
2 8, 21%
3 9, 23% 9, 43%
4 13, 33% 12, 57%
WFNS gradeb
1 23, 59% 14, 67%
2 6, 15% 6, 29%
3 1, 3%
4 6, 15% 1, 5%
5 3, 8%
mRS at 3 months post‐SAHb
0 4, 10% 4, 19%
1 23, 59% 16, 76%
2 9, 23% 1, 5%
3 2, 5%
4 1, 3%
GOS at 3 months post‐SAHb
3 1, 3% 5, 24%
4 5, 13% 6, 29%
5 33, 84% 10, 48%
Genderb
Male 13, 33% 6, 32% NSd 3, 14%
Female 26, 67% 13, 68% 18, 86%
Interventionb
Coiled 31, 79% 21, 100%
Clipped 0, 0% 0, 0%
No aneurysm identified 8, 21%
Aneurysm locationb
Anterior 25, 64% 17, 81%
Posterior 6, 15% 4, 19%
No aneurysm identified 8, 21%

Mean and rangea, number and %b, c t test, dFisher exact test, NS = P > 0.05. WFNS = World Federation of Neurosurgical Societies grade; mRS = modified Rankin Scale; GOS = Glasgow Outcome Score.